You are here

Article info

Article menu
Download PDFPDF
Short report
Could molecular pathology testing in lung cancer be more cost-effective?

Authors

  1. Correspondence to Kathy Walsh, Department of Molecular Pathology, Laboratory Medicine, Royal Infirmary of Edinburgh, Little France Crescent, Old Dalkeith Road, Edinburgh EH16 4SA, UK; kathy.walsh{at}nhslothian.scot.nhs.uk
View Full Text

Citation

Walsh K, Kheng YC, Oniscu A, et al
Could molecular pathology testing in lung cancer be more cost-effective?
Journal of Clinical Pathology 2016;69:938-941.

Publication history

  • Received April 14, 2016
  • Revised June 9, 2016
  • Accepted June 10, 2016
  • First published July 7, 2016.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/